A carregar...
Venetoclax联合低剂量阿糖胞苷治疗不耐受强化化疗的初治急性髓系白血病患者：一项Ⅲ期随机、安慰剂对照试验中中国队列结果
OBJECTIVE: To investigate the safety and efficacy of venetoclax with low-dosecytarabine（LDAC）in Chinese patients with acute myeloid leukemia（AML）who are unable to tolerateintensive induction chemotherapy. METHODS: Adults ≥ 18 years with newly diagnosed AML who wereineligible for intensive chemothera...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120118/ https://ncbi.nlm.nih.gov/pubmed/33979972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.04.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|